Quanex Building Products Announces Fourth Quarter and Full Year 2023 Results

In this article:
Quanex Building Products CorporationQuanex Building Products Corporation
Quanex Building Products Corporation

Another Record Quarter for Earnings
Margin Expansion Across All Operating Segments
Repaid $40 Million in Bank Debt in Quarter
Balance Sheet and Liquidity Remain Strong
Record Year for Cash Provided by Operating Activities

HOUSTON, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months and twelve months ended October 31, 2023.

The Company reported the following selected financial results:

 

 

 

Three Months Ended October 31,

 

Twelve Months Ended October 31,

($ in millions, except per share data)

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net Sales

 

 

$295.5

 

 

$307.5

 

 

$1,130.6

 

 

$1,221.5

 

Gross Margin

 

 

$80.0

 

 

$67.5

 

 

$277.5

 

 

$268.5

 

Gross Margin %

 

 

27.1%

 

 

21.9%

 

 

24.5%

 

 

22.0%

 

Net Income

 

 

$27.4

 

 

$24.7

 

 

$82.5

 

 

$88.3

 

Diluted EPS

 

 

$0.83

 

 

$0.75

 

 

$2.50

 

 

$2.66

 

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income

 

 

$31.2

 

 

$25.0

 

 

$90.9

 

 

$88.9

 

Adjusted Diluted EPS

 

 

$0.95

 

 

$0.75

 

 

$2.75

 

 

$2.68

 

Adjusted EBITDA

 

 

$50.8

 

 

$38.7

 

 

$159.6

 

 

$152.5

 

Adjusted EBITDA Margin %

 

 

17.2%

 

 

12.6%

 

 

14.1%

 

 

12.5%

 

 

 

 

 

 

 

 

 

 

 

Cash Provided by Operating Activities

 

 

$44.5

 

 

$48.1

 

 

$147.1

 

 

$98.0

 

Free Cash Flow

 

 

$29.6

 

 

$34.5

 

 

$109.7

 

 

$64.8

 

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, President and Chief Executive Officer, commented, “We reported another record quarter for earnings and our balance sheet and liquidity remain strong. Despite pressure on revenue due to market volume softness related to ongoing macroeconomic challenges, and some pricing pressure as raw material costs declined, we converted very well and realized margin expansion across all operating segments in both the fourth quarter and the full year. Our continued focus on controlling what we can control helped drive our improved results and we believe we are hitting our stride from an operational standpoint. Overall, we are proud of what we were able to accomplish in 2023.

“Managing working capital and generating cash is a core focus of ours, which enabled us to pay down our bank debt by $40 million during the fourth quarter alone. In fact, we generated record free cash flow in 2023.” (See Non-GAAP Terminology Definitions and Disclaimers section and Free Cash Flow reconciliation table for additional information)

Fourth Quarter and Fiscal 2023 Results Summary

Quanex reported net sales of $295.5 million during the three months ended October 31, 2023, which represents a decrease of 3.9% compared to $307.5 million for the same period of 2022. The Company reported net sales of $1.13 billion during the twelve months ended October 31, 2023, which represents a decrease of 7.4% compared to $1.22 billion for the same period of 2022. The decreases were primarily attributable to softer market demand and lower pricing in North America. Quanex reported net sales growth of 1.3% for the fourth quarter of 2023 and a decline of 2.9% in net sales for the full year in its North American Fenestration segment. Excluding the contribution from the LMI Custom Mixing assets the Company acquired on November 1, 2022, net sales in the North American Fenestration segment would have declined by 10.7% for the fourth quarter and 13.9% for the full year. In its North American Cabinet Components segment, Quanex reported a decline of 23.7% in net sales for the fourth quarter and a decline of 21.9% in net sales for the full year. Excluding foreign exchange impact, the Company realized a decrease in net sales of 3.7% for the fourth quarter and a decrease of 2.8% in net sales for the full year in its European Fenestration segment. (See Sales Analysis table for additional information)

The increase in adjusted earnings for the three months and twelve months ended October 31, 2023 was largely attributable to effective cost control, real price increases, a decline in raw material costs and a decrease in income tax expense. As such, Quanex was able to realize margin expansion in the fourth quarter and full year in each of its operating segments and on a consolidated basis.

Balance Sheet Update

As of October 31, 2023, Quanex had total debt of $70.0 million ($18.5 million excluding real-estate leases that are considered “finance” leases under U.S. GAAP) and the Company’s leverage ratio of Net Debt to LTM Adjusted EBITDA decreased to 0.1x (Net Debt free excluding these real-estate leases). As of October 31, 2023, Quanex’s LTM Adjusted EBITDA was $159.6 million and LTM Net Income, the most directly comparable GAAP measure, was $82.5 million. (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

Outlook

Mr. Wilson stated, “We enter fiscal 2024 with a somewhat cautious outlook for the first half due to the ongoing macroeconomic challenges combined with typical seasonality in our business, but we are optimistic that demand for our products will improve in the second half as consumer confidence is restored over time. However, consistent with the last two years, based on current macro indicators, recent conversations with our customers, limited transparency, and varying opinions on the outlook for 2024, we are taking a thoughtful approach to guidance for 2024. As such, we believe it would be premature to give guidance at this time and intend to re-visit guidance for 2024 when we report earnings for the first quarter. Our long-term view continues to be optimistic as the underlying fundamentals for the residential housing market remain positive.”

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, December 15, 2023 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register.vevent.com/register/BI8c21998a92f24071bb721ad032dd7661

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, vinyl fencing, solar, refrigeration, custom mixing and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

For more information contact Scott Zuehlke, Senior Vice President, Chief Financial Officer & Treasurer, at 713-877-5327 or scott.zuehlke@quanex.com.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges, asset impairment charges, other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net) and Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities. The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics, such as the recent COVID-19 pandemic) on the economy and the demand for Quanex’s products, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2022, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.


QUANEX BUILDING PRODUCTS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME

(In thousands, except per share data)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended October 31,

 

Twelve Months Ended October, 31

 

 

 

 

2023

 

 

 

2022

 

 

 

2023

 

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

295,492

 

 

$

307,532

 

 

$

1,130,583

 

 

$

1,221,502

 

 

Cost of sales

 

 

215,473

 

 

 

240,073

 

 

 

853,059

 

 

 

953,004

 

 

Selling, general and administrative

 

 

29,326

 

 

 

29,334

 

 

 

123,957

 

 

 

117,108

 

 

Depreciation and amortization

 

 

11,194

 

 

 

9,555

 

 

 

42,866

 

 

 

40,109

 

 

Operating income

 

 

39,499

 

 

 

28,570

 

 

 

110,701

 

 

 

111,281

 

 

Interest expense

 

 

(1,565

)

 

 

(710

)

 

 

(8,136

)

 

 

(2,559

)

 

Other, net

 

 

(6,110

)

 

 

136

 

 

 

(5,519

)

 

 

1,041

 

 

Income before income taxes

 

 

31,824

 

 

 

27,996

 

 

 

97,046

 

 

 

109,763

 

 

Income tax expense

 

 

(4,442

)

 

 

(3,329

)

 

 

(14,545

)

 

 

(21,427

)

 

Net income

 

$

27,382

 

 

$

24,667

 

 

$

82,501

 

 

$

88,336

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share, basic

 

$

0.84

 

 

$

0.75

 

 

$

2.51

 

 

$

2.67

 

 

Earnings per common share, diluted

 

$

0.83

 

 

$

0.75

 

 

$

2.50

 

 

$

2.66

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

 

 

32,753

 

 

 

32,916

 

 

 

32,819

 

 

 

33,048

 

 

Diluted

 

 

32,991

 

 

 

33,082

 

 

 

33,026

 

 

 

33,205

 

 

 

 

 

 

 

 

 

 

 

 

Cash dividends per share

 

$

0.08

 

 

$

0.08

 

 

$

0.32

 

 

$

0.32

 

 

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

 

 

 

 

 

 

 

 

October 31, 2023

 

October 31, 2022

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

58,474

 

 

$

55,093

 

 

Accounts receivable, net

 

 

97,311

 

 

 

96,018

 

 

Inventories, net

 

 

97,959

 

 

 

120,890

 

 

Income taxes receivable

 

 

8,298

 

 

 

-

 

 

Prepaid and other current assets

 

 

11,558

 

 

 

8,664

 

 

Total current assets

 

 

273,600

 

 

 

280,665

 

 

Property, plant and equipment, net

 

 

250,664

 

 

 

180,400

 

 

Operating lease right-of-use assets

 

 

46,620

 

 

 

56,000

 

 

Goodwill

 

 

182,956

 

 

 

137,855

 

 

Intangible assets, net

 

 

74,115

 

 

 

65,035

 

 

Other assets

 

 

3,188

 

 

 

4,662

 

 

Total assets

 

$

831,143

 

 

$

724,617

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

74,371

 

 

$

77,907

 

 

Accrued liabilities

 

 

50,319

 

 

 

52,114

 

 

Income taxes payable

 

 

384

 

 

 

1,049

 

 

Current maturities of long-term debt

 

 

2,365

 

 

 

1,046

 

 

Current operating lease liabilities

 

 

7,224

 

 

 

7,727

 

 

Total current liabilities

 

 

134,663

 

 

 

139,843

 

 

Long-term debt

 

 

66,435

 

 

 

29,628

 

 

Noncurrent operating lease liabilities

 

 

40,361

 

 

 

49,286

 

 

Deferred pension benefits

 

 

-

 

 

 

3,917

 

 

Deferred income taxes

 

 

29,133

 

 

 

22,277

 

 

Liabilities for uncertain tax positions

 

 

250

 

 

 

1,361

 

 

Other liabilities

 

 

14,747

 

 

 

13,470

 

 

Total liabilities

 

 

285,589

 

 

 

259,782

 

 

Stockholders’ equity:

 

 

 

 

 

Common stock

 

 

372

 

 

 

372

 

 

Additional paid-in-capital

 

 

251,576

 

 

 

251,947

 

 

Retained earnings

 

 

409,318

 

 

 

337,456

 

 

Accumulated other comprehensive loss

 

 

(38,141

)

 

 

(49,422

)

 

Treasury stock at cost

 

 

(77,571

)

 

 

(75,518

)

 

Total stockholders’ equity

 

 

545,554

 

 

 

464,835

 

 

Total liabilities and stockholders' equity

 

$

831,143

 

 

$

724,617

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(In thousands)

(Unaudited)

 

 

 

 

 

 

Twelve Months Ended October, 31

 

 

 

2023

 

 

 

2022

 

 

Operating activities:

 

 

 

 

Net income

$

82,501

 

 

$

88,336

 

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

42,866

 

 

 

40,109

 

 

Loss on the disposition of capital assets

 

278

 

 

 

109

 

 

Stock-based compensation

 

2,521

 

 

 

2,291

 

 

Deferred income tax

 

5,147

 

 

 

2,097

 

 

Other, net

 

1,529

 

 

 

1,905

 

 

Changes in assets and liabilities:

 

 

 

 

Decrease in accounts receivable

 

6,969

 

 

 

6,945

 

 

Decrease (increase) in inventory

 

30,024

 

 

 

(32,035

)

 

Increase in other current assets

 

(1,880

)

 

 

(970

)

 

Decrease in accounts payable

 

(11,611

)

 

 

(3,047

)

 

Decrease in accrued liabilities

 

(4,249

)

 

 

(3,159

)

 

Decrease in income taxes payable

 

(9,009

)

 

 

(5,192

)

 

(Decrease) increase in deferred pension benefits

 

(359

)

 

 

77

 

 

Increase in other long-term liabilities

 

683

 

 

 

305

 

 

Other, net

 

1,642

 

 

 

194

 

 

Cash provided by operating activities

 

147,052

 

 

 

97,965

 

 

Investing activities:

 

 

 

 

Business acquisition

 

(91,302

)

 

 

-

 

 

Capital expenditures

 

(37,390

)

 

 

(33,121

)

 

Proceeds from disposition of capital assets

 

253

 

 

 

159

 

 

Cash used for investing activities

 

(128,439

)

 

 

(32,962

)

 

Financing activities:

 

 

 

 

Borrowings under credit facilities

 

102,000

 

 

 

70,500

 

 

Repayments of credit facility borrowings

 

(100,000

)

 

 

(95,500

)

 

Debt issuance costs

 

-

 

 

 

(1,210

)

 

Repayments of other long-term debt

 

(2,567

)

 

 

(1,747

)

 

Common stock dividends paid

 

(10,639

)

 

 

(10,598

)

 

Issuance of common stock

 

1,215

 

 

 

689

 

 

Payroll tax paid to settle shares forfeited upon vesting of stock

 

(567

)

 

 

(1,413

)

 

Purchase of treasury stock

 

(5,593

)

 

 

(6,600

)

 

Cash used for financing activities

 

(16,151

)

 

 

(45,879

)

 

Effect of exchange rate changes on cash and cash equivalents

 

919

 

 

 

(4,092

)

 

Increase in cash and cash equivalents

 

3,381

 

 

 

15,032

 

 

Cash and cash equivalents at beginning of period

 

55,093

 

 

 

40,061

 

 

Cash and cash equivalents at end of period

$

58,474

 

 

$

55,093

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION

FREE CASH FLOW AND NET DEBT RECONCILIATION

(In thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended October 31,

 

Twelve Months Ended October, 31

 

 

 

 

2023

 

2022

 

2023

 

2022

 

Cash provided by operating activities

 

 

$44,493

 

$48,111

 

$147,052

 

$97,965

 

Capital expenditures

 

 

(14,940)

 

(13,633)

 

(37,390)

 

(33,121)

 

Free Cash Flow

 

 

$29,553

 

$34,478

 

$109,662

 

$64,844

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of October 31,

 

 

 

 

 

 

2023

 

2022

 

 

 

 

 

Revolving credit facility

 

 

$15,000

 

$13,000

 

 

 

 

 

Finance lease obligations (1)

 

 

55,000

 

19,202

 

 

 

 

 

Total debt (2)

 

 

70,000

 

32,202

 

 

 

 

 

Less: Cash and cash equivalents

 

 

58,474

 

55,093

 

 

 

 

 

Net Debt

 

 

$11,526

 

($22,891)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes $51.5 million and $17.7 million in real estate lease liabilities considered finance leases under U.S. GAAP as of October 31, 2023 and October 31, 2022, respectively.

 

 

 

 

 

(2) Excludes outstanding letters of credit.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION

NON-GAAP FINANCIAL MEASURE DISCLOSURE

LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION

(In thousands, except per share data)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Last Twelve Months Adjusted EBITDA

 

Three Months Ended
October 31, 2023

 

Three Months Ended
July 31, 2023

 

Three Months Ended
April 30, 2023

 

Three Months Ended
January 31, 2023

 

Total

 

 

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Net income as reported

 

$

27,382

 

 

$

31,698

 

 

$

21,512

 

$

1,909

 

 

$

82,501

 

Income tax expense

 

 

4,442

 

 

 

4,099

 

 

 

5,551

 

 

453

 

 

 

14,545

 

Other, net

 

 

6,110

 

 

 

(402

)

 

 

29

 

 

(218

)

 

 

5,519

 

Interest expense

 

 

1,565

 

 

 

2,068

 

 

 

2,244

 

 

2,259

 

 

 

8,136

 

Depreciation and amortization

 

 

11,194

 

 

 

10,596

 

 

 

10,456

 

 

10,620

 

 

 

42,866

 

EBITDA

 

 

50,693

 

 

 

48,059

 

 

 

39,792

 

 

15,023

 

 

 

153,567

 

Cost of sales (1)

 

 

(35

)

 

 

-

 

 

 

48

 

 

-

 

 

 

13

 

Selling, general and administrative (1),(2)

 

 

109

 

 

 

395

 

 

 

63

 

 

5,448

 

 

 

6,015

 

Adjusted EBITDA

 

$

50,767

 

 

$

48,454

 

 

$

39,903

 

$

20,471

 

 

$

159,595

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Loss on damage to manufacturing facilities caused by weather.

 

(2) Transaction and advisory fees.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

QUANEX BUILDING PRODUCTS CORPORATION

NON-GAAP FINANCIAL MEASURE DISCLOSURE

(In thousands, except per share data)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted Net Income and Adjusted EPS

 

Three Months Ended
October 31, 2023

 

Three Months Ended
October 31, 2022

 

Twelve Months Ended
October 31, 2023

 

Twelve Months Ended
October 31, 2022

 

 

 

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

Net Income

 

Diluted EPS

 

 

Net income as reported

 

$

27,382

 

 

$

0.83

 

 

$

24,667

 

 

$

0.75

 

 

$

82,501

 

 

$

2.50

 

 

$

88,336

 

 

$

2.66

 

 

 

Net income reconciling items from below

 

 

3,851

 

 

$

0.12

 

 

 

290

 

 

$

-

 

 

 

8,401

 

 

$

0.25

 

 

 

581

 

 

$

0.02

 

 

 

Adjusted net income and adjusted EPS

 

$

31,233

 

 

$

0.95

 

 

$

24,957

 

 

$

0.75

 

 

$

90,902

 

 

$

2.75

 

 

$

88,917

 

 

$

2.68

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted EBITDA

 

Three Month Ended
October 31, 2023

 

Three Months Ended
October 31, 2022

 

Twelve Months Ended
October 31, 2023

 

Twelve Months Ended
October 31, 2022

 

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

 

Net income as reported

 

$

27,382

 

 

 

 

$

24,667

 

 

 

 

$

82,501

 

 

 

 

$

88,336

 

 

 

 

 

Income tax expense

 

 

4,442

 

 

 

 

 

3,329

 

 

 

 

 

14,545

 

 

 

 

 

21,427

 

 

 

 

 

Other, net

 

 

6,110

 

 

 

 

 

(136

)

 

 

 

 

5,519

 

 

 

 

 

(1,041

)

 

 

 

 

Interest expense

 

 

1,565

 

 

 

 

 

710

 

 

 

 

 

8,136

 

 

 

 

 

2,559

 

 

 

 

 

Depreciation and amortization

 

 

11,194

 

 

 

 

 

9,555

 

 

 

 

 

42,866

 

 

 

 

 

40,109

 

 

 

 

 

EBITDA

 

 

50,693

 

 

 

 

 

38,125

 

 

 

 

 

153,567

 

 

 

 

 

151,390

 

 

 

 

 

EBITDA reconciling items from below

 

 

74

 

 

 

 

 

564

 

 

 

 

 

6,028

 

 

 

 

 

1,114

 

 

 

 

 

Adjusted EBITDA

 

$

50,767

 

 

 

 

$

38,689

 

 

 

 

$

159,595

 

 

 

 

$

152,504

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciling Items

 

Three Months Ended
October 31, 2023

 

Three Months Ended
October 31, 2022

 

Twelve Months Ended
October 31, 2023

 

Twelve Months Ended
October 31, 2022

 

 

 

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

 

Net sales

 

$

295,492

 

 

$

-

 

 

$

307,532

 

 

$

-

 

 

$

1,130,583

 

 

$

-

 

 

$

1,221,502

 

 

$

-

 

 

 

Cost of sales

 

 

215,473

 

 

 

35

 

(1

)

 

240,073

 

 

 

-

 

 

 

853,059

 

 

 

(13

)

(1

)

 

953,004

 

 

 

-

 

 

 

Selling, general and administrative

 

 

29,326

 

 

 

(109

)

(1),(2)

 

29,334

 

 

 

(564

)

(2

)

 

123,957

 

 

 

(6,015

)

(1),(2)

 

117,108

 

 

 

(1,114

)

(2

)

 

EBITDA

 

 

50,693

 

 

 

74

 

 

 

38,125

 

 

 

564

 

 

 

153,567

 

 

 

6,028

 

 

 

151,390

 

 

 

1,114

 

 

 

Depreciation and amortization

 

 

11,194

 

 

 

-

 

 

 

9,555

 

 

 

-

 

 

 

42,866

 

 

 

-

 

 

 

40,109

 

 

 

-

 

 

 

Operating income

 

 

39,499

 

 

 

74

 

 

 

28,570

 

 

 

564

 

 

 

110,701

 

 

 

6,028

 

 

 

111,281

 

 

 

1,114

 

 

 

Interest expense

 

 

(1,565

)

 

 

-

 

 

 

(710

)

 

 

-

 

 

 

(8,136

)

 

 

-

 

 

 

(2,559

)

 

 

-

 

 

 

Other, net

 

 

(6,110

)

 

 

5,232

 

(3

)

 

136

 

 

 

(222

)

(3

)

 

(5,519

)

 

 

5,196

 

(3

)

 

1,041

 

 

 

(386

)

(3

)

 

Income before income taxes

 

 

31,824

 

 

 

5,306

 

 

 

27,996

 

 

 

342

 

 

 

97,046

 

 

 

11,224

 

 

 

109,763

 

 

 

728

 

 

 

Income tax expense

 

 

(4,442

)

 

 

(1,455

)

(4

)

 

(3,329

)

 

 

(52

)

(4

)

 

(14,545

)

 

 

(2,823

)

(4

)

 

(21,427

)

 

 

(147

)

(4

)

 

Net income

 

$

27,382

 

 

$

3,851

 

 

$

24,667

 

 

$

290

 

 

$

82,501

 

 

$

8,401

 

 

$

88,336

 

 

$

581

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share

 

$

0.83

 

 

 

 

$

0.75

 

 

 

 

$

2.50

 

 

 

 

$

2.66

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Loss on damage to manufacturing facilities caused by weather.

 

 

 

 

 

 

 

 

 

 

(2) Transaction and advisory fees.

 

 

 

 

 

 

 

 

 

 

(3) Foreign currency translation losses (gains) and pension settlement expense.

 

 

 

 

 

 

 

 

 

 

(4)Tax impact of net income reconciling items.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION

SELECTED SEGMENT DATA

(In thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.

 

 

NA Fenestration

 

EU Fenestration

 

NA Cabinet Components

 

Unallocated Corp & Other

 

Total

Three months ended October 31, 2023

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

180,446

 

 

$

64,170

 

 

$

51,868

 

 

$

(992

)

 

$

295,492

 

 

Cost of sales

 

 

135,490

 

 

 

39,070

 

 

 

41,488

 

 

 

(575

)

 

 

215,473

 

 

Gross Margin

 

 

44,956

 

 

 

25,100

 

 

 

10,380

 

 

 

(417

)

 

 

80,019

 

 

Gross Margin %

 

 

24.9

%

 

 

39.1

%

 

 

20.0

%

 

 

 

 

27.1

%

 

Selling, general and administrative

 

 

15,272

 

 

 

8,354

 

 

 

5,135

 

 

 

565

 

 

 

29,326

 

 

Depreciation and amortization

 

 

5,211

 

 

 

2,714

 

 

 

3,220

 

 

 

49

 

 

 

11,194

 

 

Operating income (loss)

 

 

24,473

 

 

 

14,032

 

 

 

2,025

 

 

 

(1,031

)

 

 

39,499

 

 

Depreciation and amortization

 

 

5,211

 

 

 

2,714

 

 

 

3,220

 

 

 

49

 

 

 

11,194

 

 

EBITDA

 

 

29,684

 

 

 

16,746

 

 

 

5,245

 

 

 

(982

)

 

 

50,693

 

 

Loss on damage to manufacturing facilities (Cost of sales)

 

 

(35

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(35

)

 

Loss on damage to manufacturing facilities (SG&A)

 

 

-

 

 

 

-

 

 

 

(131

)

 

 

-

 

 

 

(131

)

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

240

 

 

 

240

 

 

Adjusted EBITDA

 

$

29,649

 

 

$

16,746

 

 

$

5,114

 

 

$

(742

)

 

$

50,767

 

 

Adjusted EBITDA Margin %

 

 

16.4

%

 

 

26.1

%

 

 

9.9

%

 

 

 

 

17.2

%

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended October 31, 2022

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

178,175

 

 

$

62,104

 

 

$

67,993

 

 

$

(740

)

 

$

307,532

 

 

Cost of sales

 

 

141,395

 

 

 

42,121

 

 

 

56,904

 

 

 

(347

)

 

 

240,073

 

 

Gross Margin

 

 

36,780

 

 

 

19,983

 

 

 

11,089

 

 

 

(393

)

 

 

67,459

 

 

Gross Margin %

 

 

20.6

%

 

 

32.2

%

 

 

16.3

%

 

 

 

 

21.9

%

 

Selling, general and administrative

 

 

15,636

 

 

 

7,686

 

 

 

6,111

 

 

 

(99

)

 

 

29,334

 

 

Depreciation and amortization

 

 

4,032

 

 

 

2,256

 

 

 

3,177

 

 

 

90

 

 

 

9,555

 

 

Operating income (loss)

 

 

17,112

 

 

 

10,041

 

 

 

1,801

 

 

 

(384

)

 

 

28,570

 

 

Depreciation and amortization

 

 

4,032

 

 

 

2,256

 

 

 

3,177

 

 

 

90

 

 

 

9,555

 

 

EBITDA

 

 

21,144

 

 

 

12,297

 

 

 

4,978

 

 

 

(294

)

 

 

38,125

 

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

564

 

 

 

564

 

 

Adjusted EBITDA

 

$

21,144

 

 

$

12,297

 

 

$

4,978

 

 

$

270

 

 

$

38,689

 

 

Adjusted EBITDA Margin %

 

 

11.9

%

 

 

19.8

%

 

 

7.3

%

 

 

 

 

12.6

%

 

 

 

 

 

 

 

 

 

 

 

 

Twelve months ended October 31, 2023

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

667,482

 

 

$

250,774

 

 

$

215,445

 

 

$

(3,118

)

 

$

1,130,583

 

 

Cost of sales

 

 

517,805

 

 

 

158,491

 

 

 

178,210

 

 

 

(1,447

)

 

 

853,059

 

 

Gross Margin

 

 

149,677

 

 

 

92,283

 

 

 

37,235

 

 

 

(1,671

)

 

 

277,524

 

 

Gross Margin %

 

 

22.4

%

 

 

36.8

%

 

 

17.3

%

 

 

 

 

24.5

%

 

Selling, general and administrative

 

 

56,979

 

 

 

32,350

 

 

 

21,074

 

 

 

13,554

 

 

 

123,957

 

 

Depreciation and amortization

 

 

20,539

 

 

 

9,849

 

 

 

12,208

 

 

 

270

 

 

 

42,866

 

 

Operating income (loss)

 

 

72,159

 

 

 

50,084

 

 

 

3,953

 

 

 

(15,495

)

 

 

110,701

 

 

Depreciation and amortization

 

 

20,539

 

 

 

9,849

 

 

 

12,208

 

 

 

270

 

 

 

42,866

 

 

EBITDA

 

 

92,698

 

 

 

59,933

 

 

 

16,161

 

 

 

(15,225

)

 

 

153,567

 

 

Loss on damage to manufacturing facilities (Cost of sales)

 

 

-

 

 

 

-

 

 

 

13

 

 

 

-

 

 

 

13

 

 

Loss on damage to manufacturing facilities (SG&A)

 

 

-

 

 

 

-

 

 

 

69

 

 

 

-

 

 

 

69

 

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,946

 

 

 

5,946

 

 

Adjusted EBITDA

 

$

92,698

 

 

$

59,933

 

 

$

16,243

 

 

$

(9,279

)

 

$

159,595

 

 

Adjusted EBITDA Margin %

 

 

13.9

%

 

 

23.9

%

 

 

7.5

%

 

 

 

 

14.1

%

 

 

 

 

 

 

 

 

 

 

 

 

Twelve months ended October 31, 2022

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

687,458

 

 

$

262,058

 

 

$

275,704

 

 

$

(3,718

)

 

$

1,221,502

 

 

Cost of sales

 

 

537,900

 

 

 

180,268

 

 

 

236,695

 

 

 

(1,859

)

 

 

953,004

 

 

Gross Margin

 

 

149,558

 

 

 

81,790

 

 

 

39,009

 

 

 

(1,859

)

 

 

268,498

 

 

Gross Margin %

 

 

21.8

%

 

 

31.2

%

 

 

14.1

%

 

 

 

 

22.0

%

 

Selling, general and administrative

 

 

58,735

 

 

 

31,846

 

 

 

21,934

 

 

 

4,593

 

 

 

117,108

 

 

Depreciation and amortization

 

 

16,253

 

 

 

9,674

 

 

 

13,830

 

 

 

352

 

 

 

40,109

 

 

Operating income (loss)

 

 

74,570

 

 

 

40,270

 

 

 

3,245

 

 

 

(6,804

)

 

 

111,281

 

 

Depreciation and amortization

 

 

16,253

 

 

 

9,674

 

 

 

13,830

 

 

 

352

 

 

 

40,109

 

 

EBITDA

 

 

90,823

 

 

 

49,944

 

 

 

17,075

 

 

 

(6,452

)

 

 

151,390

 

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,114

 

 

 

1,114

 

 

Adjusted EBITDA

 

$

90,823

 

 

$

49,944

 

 

$

17,075

 

 

$

(5,338

)

 

$

152,504

 

 

Adjusted EBITDA Margin %

 

 

13.2

%

 

 

19.1

%

 

 

6.2

%

 

 

 

 

12.5

%

 

 

 

 

 

 

 

 

 

 

 

 


QUANEX BUILDING PRODUCTS CORPORATION

SALES ANALYSIS

(In thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended October 31,

 

Twelve Months Ended October, 31

 

 

 

 

2023

 

 

 

2022

 

 

 

2023

 

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

NA Fenestration: (1)

 

 

 

 

 

 

 

 

 

United States - fenestration

$

138,783

 

 

$

162,147

 

 

$

518,396

 

 

$

609,572

 

 

 

International - fenestration

 

8,081

 

 

 

4,954

 

 

 

30,100

 

 

 

35,906

 

 

 

United States - non-fenestration

 

29,267

 

 

 

6,922

 

 

 

103,090

 

 

 

29,039

 

 

 

International - non-fenestration

 

4,315

 

 

 

4,152

 

 

 

15,896

 

 

 

12,941

 

 

 

 

$

180,446

 

 

$

178,175

 

 

$

667,482

 

 

$

687,458

 

 

EU Fenestration: (2)

 

 

 

 

 

 

 

 

 

International - fenestration

$

49,862

 

 

$

46,329

 

 

$

191,871

 

 

$

194,854

 

 

 

International - non-fenestration

 

14,308

 

 

 

15,775

 

 

 

58,903

 

 

 

67,204

 

 

 

 

$

64,170

 

 

$

62,104

 

 

$

250,774

 

 

$

262,058

 

 

NA Cabinet Components:

 

 

 

 

 

 

 

 

 

United States - fenestration

$

4,286

 

 

$

4,408

 

 

$

16,899

 

 

$

17,696

 

 

 

United States - non-fenestration

 

47,092

 

 

 

62,818

 

 

 

195,866

 

 

 

254,726

 

 

 

International - non-fenestration

 

490

 

 

 

767

 

 

 

2,680

 

 

 

3,282

 

 

 

 

$

51,868

 

 

$

67,993

 

 

$

215,445

 

 

$

275,704

 

 

Unallocated Corporate & Other:

 

 

 

 

 

 

 

 

 

Eliminations

$

(992

)

 

$

(740

)

 

$

(3,118

)

 

$

(3,718

)

 

 

 

$

(992

)

 

$

(740

)

 

$

(3,118

)

 

$

(3,718

)

 

 

 

 

 

 

 

 

 

 

 

Net Sales

$

295,492

 

 

$

307,532

 

 

$

1,130,583

 

 

$

1,221,502

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes the net sales from the acquisition of LMI of $21.4 million and $75.6 million for the three and twelve months ended October 31, 2023, respectively.

 

(2) Reflects an increase of $4.5 million and a reduction of $4.1 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2023, respectively.

 

 

 

 

 

 

 

 

 

 

 


Advertisement